Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Creating a Microrobot to One Day Tackle Cancer

In this interview, we speak to Birgül Akolpoglu about her latest research into microrobotics and how these biohybrid microrobots could one day be used to tackle cancer.

27 Jul 2022

Elevated insulin resistance, advanced cell aging associated with childhood poverty

Black adolescents who lived in poverty and were less optimistic about the future showed accelerated aging in their immune cells and were more likely to have elevated insulin resistance at ages 25-29, researchers found.

25 Jul 2022

UMass Amherst scientist to study how embryonic exposure to pollutants may increase diabetes risk

A University of Massachusetts Amherst environmental health scientist has received a $2.44 million, five-year grant renewal from the National Institutes of Health to continue her research into how embryonic exposure to certain common pollutants may put people at risk for diabetes and other metabolic health conditions later in life.

22 Jul 2022

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.

22 Jul 2022

Hypertension linked to double the risk of severe COVID-19 despite booster vaccination

Having high blood pressure more than doubled a person's risk for hospitalization from an Omicron-variant COVID-19 infection - even despite full vaccination including a booster dose of the COVID-19 vaccines, in an analysis of adults hospitalized with COVID-19 in Los Angeles between December 2021 and April 2022, according to new research published today in Hypertension, an American Heart Association journal.

20 Jul 2022

Wearable activity trackers are effective in increasing physical activity and improving health

New findings from Australian researchers have endorsed what millions of people around the world believe: fitness trackers, pedometers and smart watches motivate us to exercise more and lose weight.

20 Jul 2022

Keto and Mediterranean diets are good for controlling blood glucose levels and aiding weight loss

A low-carbohydrate diet is generally recommended for people who have Type 2 diabetes or who are at risk of developing the disease.

20 Jul 2022

New microbiome-based predictive models to forecast human health outcomes

A new approach that uses artificial intelligence (AI) shows how to use microorganisms in the body and molecules in cells to predict human health outcomes, according to Penn State College of Medicine and University of Texas Southwestern Medical Center researchers.

19 Jul 2022

Overstrict salt intake restriction could harm patients with heart failure with preserved ejection

Restricting salt intake is considered a key component of heart failure treatment, but restricting it too much may actually worsen the outcomes for people with a common form of the condition, suggests research published online in the journal Heart.

19 Jul 2022

Infant formula marketing directly affects breastfeeding rates

Formula milk companies continue to defy international regulations and target health centers to market their products, a WHO study on formula marketing and its impact on breastfeeding shows.

18 Jul 2022

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin, have no choice but to inject themselves regularly with artificial insulin in order to survive.

18 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Children born to mothers with PCOS have increased risk of developing childhood illnesses

Children born to mothers with polycystic ovary syndrome (PCOS) have an increased risk of developing infections, allergies and other childhood illnesses by the age of 13, according to the largest study to investigate this.

14 Jul 2022

Researchers may be one step closer to preventing Type 1 diabetes

Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

In a new study, researchers reported that Pfizer’s BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 does not affect the honeymoon phase of type 1 diabetes (T1D).

13 Jul 2022

What is the long-term protection against COVID-19?

A new study describes the immunologic parameters associated with protection from COVID-19.

12 Jul 2022

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

A new study has investigated the interplay of FH and genome-wide PRS

11 Jul 2022

Diabetes not strongly associated with in-hospital COVID mortality

In a recent study posted to the medRxiv* preprint server, researchers assessed the association between diabetes mellitus (type 2 diabetes) and mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at multiple centers in Canada and Denmark.

8 Jul 2022

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

While patients with diabetes on Medicare Advantage plans are more likely to receive preventive treatments, they were less likely to be prescribed newer, more expensive medications and were more likely to have higher blood pressure and worse blood glucose control than patients on Medicare Fee-For-Service plans, according to a new study led by a University of Pittsburgh School of Medicine physician-scientist.

7 Jul 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Creating a Microrobot to One Day Tackle Cancer

Elevated insulin resistance, advanced cell aging associated with childhood poverty

UMass Amherst scientist to study how embryonic exposure to pollutants may increase diabetes risk

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

Hypertension linked to double the risk of severe COVID-19 despite booster vaccination

Wearable activity trackers are effective in increasing physical activity and improving health

Keto and Mediterranean diets are good for controlling blood glucose levels and aiding weight loss

New microbiome-based predictive models to forecast human health outcomes

Overstrict salt intake restriction could harm patients with heart failure with preserved ejection

Infant formula marketing directly affects breastfeeding rates

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Children born to mothers with PCOS have increased risk of developing childhood illnesses

Researchers may be one step closer to preventing Type 1 diabetes

People with non-alcoholic fatty liver disease may have higher risk of dementia

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

What is the long-term protection against COVID-19?

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

Diabetes not strongly associated with in-hospital COVID mortality

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in